Print   



 

Press Release

25 June 2009

Medicsight PLC

('Medicsight' or 'the Company')

Medicsight launches ColonCAD™ online CTC platform

Medicsight PLC (AIM:MDST), industry leader in the development of Computer-Aided Detection (CAD) and image analysis software which assists in the early detection and diagnosis of disease, is pleased to announce the launch of its online product, MedicRead™ 3.0 Colon. This online offering makes the benefits of Medicsight's ColonCAD software truly accessible to all radiologists for the first time. 

MedicRead™ 3.0 Colon is the Company's own advanced visualisation platform, integrated with Medicsight's ColonCAD™ software to help radiologists read computer tomography (CT) scans for the detection of colonic polyps, which may be the precursors of colon cancer.  The online version is downloadable from www.medicsight.com making CAD accessible to the global radiology community.  MedicRead™ 3.0 Colon online will be sold as a total solution with either a single list price or available on a monthly installment basis over 12 months.

Allan Rowley, Chief Executive of Medicsight commented, 'The launch of our online MedicRead 3.0 Colon platform provides the Company with an additional revenue stream.  It is the only visualisation workstation that can be accessed and downloaded online enabling the international radiology community to experience and take advantage of the clinical benefits of ColonCAD.'

Access to Medicsight's ColonCAD™ software is currently available through the Company's
partners' advanced 3D visualisation platforms. As part of the Company's ongoing commitment to radiologists and to improving the early detection of colorectal cancer, Medicsight has developed
MedicRead 3.0 Colon. This is a competitively priced, stand-alone, CTC visualisation workstation,
incorporating the latest version of ColonCAD 4.0 as well as Medicsight's MedicServer™ 
technology. MedicRead 3.0 Colon offers a valuable centralised pre-processing platform that accepts DICOM CT image data from either the CT console or any PACS system.

The new online application is being showcased on the Medicsight booth (number 13) at ESGAR 2009, which is taking place this week in Valencia. Additionally, a 30 day free trial version of the 
software can be downloaded from the Medicsight new website www.medicsight.com allowing
radiologists to experience the benefits of ColonCAD first hand. 

MedicRead 3.0 Colon is not currently available for sale in the United States.

- ENDS -

For further information:

Medicsight PLC	www.medicsight.com
Allan Rowley	+44 (0)20 7605 7950
Daniel Stewart & Company PLC
Simon Leathers / Charlotte Stranner	+44 (0) 20 7776 6550
Media enquiries:
Abchurch Communications	+44 (0) 20 7398 7700
Heather Salmond / Stephanie Cuthbert / Simone Alves	+44 (0) 20 7398 7718
stephanie.cuthbert@abchurch-group.com	www.abchurch-group.com

Notes to editors 

Medicsight PLC is a UK-headquartered, research driven, leading developer of computer-aided detection (CAD) and image analysis software for the medical imaging market. The CAD software automatically highlights suspicious areas on computerised tomography (CT) scans of the colon and lung, helping radiologists to identify, measure and analyse potential disease and early indicators of disease. Medicsight's CAD software has been validated using one of the world's largest and most population diverse databases of verified patient CT scan data. Medicsight's ColonCAD™ and LungCAD™ software products are seamlessly integrated with the advanced 3D visualisation workstations of several industry-leading imaging equipment partners.

About Computer-Aided Detection

With increasingly sophisticated radiological imaging hardware such as Multi-Detector CT scanners, radiologists are facing a growing challenge in the amount of detailed patient image data that they must review for each patient examination. Some CT scan examinations generate as many as 2000 images per patient. Review of this data by the radiologist is not only time-consuming but also prone to error due to reader fatigue. CAD software can help the reviewing radiologist by analysing the image data and automatically highlighting suspicious regions of interest for closer inspection. Without CAD software some potential abnormalities or areas of disease may be overlooked. This can be critical for diagnosis and the management of patient outcomes as early detection of disease greatly increases the probability of successful treatment and a positive therapeutic outcome. In addition to supporting individual radiologists CAD also has the potential to help standardise CT interpretation across both individuals and institutions thereby supporting population based screening programmes.

About Medicsight's CAD software

Medicsight's ColonCAD™ and LungCAD™ software use an advanced CAD algorithm to analyse CT scans of the colon and lung and automatically highlight suspicious areas that may be indicators of disease. CAD may highlight areas easily overlooked by the reviewing radiologist, such as small lesions or regions that are hidden from view behind folds in the colon or normal structures and surrounding tissue in the lung.

Both CAD products seamlessly integrate with the advanced 3D visualisation platforms of industry-leading imaging equipment partners. The integrated systems provide sophisticated image viewing capabilities, including 3D reconstructed image data, with the added advantage of demonstrating automatic CAD findings to assist clinical end users in the detection and analysis of disease. This allows clinical end users to perform either a 'second read', where CAD findings are displayed to the user after completion of an initial review of the CT scan data, or a 'concurrent read' where CAD findings are displayed during the user's initial review of the original CT scan images.

Since inception, Medicsight has developed close and lasting relationships with some of the world's foremost clinicians in product related areas. This provides the Company with a wealth of clinical expertise and dedicated clinical research to support ongoing product development. Medicsight also collaborates with a number of leading academic institutions and clinical research programmes worldwide to develop the Company's comprehensive database of population diverse verified patient CT scan data, thus allowing Medicsight's products to be validated to the highest possible standards.

ENDMSCSEFFLISUSESM